Sanuwave Health sees Q1 revenue $5.7M-$5.9, up 51%-56% over 1Q23
PremiumThe FlySanuwave Health sees Q1 revenue $5.7M-$5.9, up 51%-56% over 1Q23
5M ago
Sanuwave Health Announces CFO Transition and New Financial Strategy
Premium
Company Announcements
Sanuwave Health Announces CFO Transition and New Financial Strategy
6M ago
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Premium
Press Releases
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
6M ago
Sanuwave Health Announces New Financial Obligation Registration
PremiumMarket NewsSanuwave Health Announces New Financial Obligation Registration
8M ago
Sanuwave Health Secures Funding with Asset-Backed Notes
Premium
Market News
Sanuwave Health Secures Funding with Asset-Backed Notes
8M ago
Sanuwave Health announces special meeting to vote on business combination
Premium
The Fly
Sanuwave Health announces special meeting to vote on business combination
8M ago
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
PremiumPress ReleasesSANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
12M ago
Sanuwave Health sees Q3 revenue $4.7M-$4.9M
Premium
The Fly
Sanuwave Health sees Q3 revenue $4.7M-$4.9M
12M ago
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
Premium
Press Releases
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100